Dallah Healthcare’s third-quarter 2026 net profit reached SAR436 million, boosted by a one-off disposal gain. Revenue rose 2.3% year on year to SAR1.086 billion.
Underlying earnings matter
In its 4 November report, anb capital calculated profit excluding non-recurring items at SAR79.5 million, down 28.6%. The distinction matters when assessing whether earnings growth can continue.
Market News angle
anb capital retained its Neutral rating and SAR115 target, unchanged from its previous update, on a 12-month valuation horizon. Reported profit missed its estimate by 12.6%, reflecting weaker-than-expected revenue. This is the research house’s assessment.
What should investors watch?
The focus is recurring profitability and financing costs in subsequent results. The target is an analyst valuation, with no guaranteed return.
Illustrative image of the healthcare sector.
اكتشاف المزيد من Market News | أخبار الأسواق
اشترك للحصول على أحدث التدوينات المرسلة إلى بريدك الإلكتروني.
تعليق واحد
تنبيه: نتائج دله الصحية للربع الثالث 2026 وتقييم العربي المالية